BlackRock Health Sciences Trust (NYSE:BME) Shares Bought by Consolidated Portfolio Review Corp

Consolidated Portfolio Review Corp grew its position in shares of BlackRock Health Sciences Trust (NYSE:BME) by 7.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,574 shares of the company’s stock after purchasing an additional 2,853 shares during the period. Consolidated Portfolio Review Corp’s holdings in BlackRock Health Sciences Trust were worth $1,785,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in BME. HBK Sorce Advisory LLC boosted its holdings in BlackRock Health Sciences Trust by 14.4% in the first quarter. HBK Sorce Advisory LLC now owns 7,009 shares of the company’s stock valued at $290,000 after purchasing an additional 884 shares during the last quarter. Raymond James Trust N.A. boosted its stake in shares of BlackRock Health Sciences Trust by 8.1% during the 2nd quarter. Raymond James Trust N.A. now owns 22,036 shares of the company’s stock valued at $900,000 after buying an additional 1,649 shares during the last quarter. Janney Montgomery Scott LLC grew its position in shares of BlackRock Health Sciences Trust by 8.3% during the first quarter. Janney Montgomery Scott LLC now owns 27,837 shares of the company’s stock worth $1,154,000 after buying an additional 2,122 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in shares of BlackRock Health Sciences Trust by 4.3% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 54,605 shares of the company’s stock worth $2,231,000 after buying an additional 2,240 shares during the last quarter. Finally, Calamos Advisors LLC raised its holdings in BlackRock Health Sciences Trust by 46.4% in the second quarter. Calamos Advisors LLC now owns 7,884 shares of the company’s stock valued at $322,000 after acquiring an additional 2,500 shares in the last quarter.

BlackRock Health Sciences Trust Price Performance

BME stock traded down $0.22 during mid-day trading on Friday, hitting $40.72. 14,742 shares of the company were exchanged, compared to its average volume of 31,754. The firm has a fifty day simple moving average of $41.80 and a 200 day simple moving average of $40.79. BlackRock Health Sciences Trust has a twelve month low of $35.53 and a twelve month high of $42.86.

BlackRock Health Sciences Trust Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be paid a $0.213 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.56 dividend on an annualized basis and a yield of 6.28%.

BlackRock Health Sciences Trust Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.